Skip to main content

Pain Management

Pain is the reason most patients seek care, yet it is invisible on any monitor — you cannot see it on a telemetry strip or measure it in a blood tube. That is exactly why pain management is one of the most human, and most clinically demanding, parts of nursing. As Margo McCaffery famously defined it, "pain is whatever the experiencing person says it is, existing whenever the experiencing person says it does." At the bedside you are the patient's most constant advocate: you assess it, treat it within your orders, reassess whether the treatment worked, and watch vigilantly for the harms that pain medicines themselves can cause. Doing this well relieves suffering and speeds healing; doing it poorly leaves patients in agony — or, at the other extreme, oversedated and not breathing.

Learning Objectives

  • Assess pain accurately using self-report and validated tools across the lifespan, including nonverbal patients.
  • Distinguish acute, chronic, nociceptive, and neuropathic pain and match interventions accordingly.
  • Apply the WHO analgesic ladder to guide multimodal, step-wise analgesia.
  • Administer opioids safely, monitor sedation and respiratory status, and recognize and reverse overdose.
  • Integrate non-pharmacologic methods into a realistic care plan.
  • Explain the history and pitfalls of pain as the "fifth vital sign" and current safe-practice standards.

Quick Answer

Effective pain management starts with believing the patient and assessing systematically — location, quality, intensity, timing, and what makes it better or worse — using a validated scale (0–10, Wong-Baker FACES, or a behavioral tool for nonverbal patients). Treatment follows a multimodal, step-wise approach modeled on the WHO analgesic ladder: non-opioids (acetaminophen, NSAIDs) for mild pain, weak opioids for moderate pain, and strong opioids for severe pain, plus adjuvants and non-drug measures at every step. Opioids are highly effective but carry the risk of respiratory depression, so monitor sedation level first (sedation precedes respiratory depression) and keep naloxone available. Reassess after every intervention — an unreassessed dose is an incomplete nursing action. Always work within provider orders and your scope, and escalate when pain is uncontrolled or when safety is threatened.

Where It Came From

For most of medical history, pain was treated as an inevitable byproduct of disease rather than a problem in its own right. Florence Nightingale, in the 1850s, recognized that a patient's comfort — quiet, warmth, position, rest — was itself therapeutic, an early insight that suffering worsens outcomes. But systematic pain assessment lagged for over a century. Until the late 20th century, clinicians routinely undertreated pain, partly from exaggerated fear of addiction and partly because there was no standard way to measure something so subjective.

The pivotal shift came from the recognition that "what gets measured gets managed." In the 1990s, pain specialists — building on McCaffery's work from the 1960s–70s asserting the primacy of patient self-report — argued that pain should be assessed as routinely as temperature, pulse, respirations, and blood pressure. The American Pain Society coined the phrase pain as the "fifth vital sign" in 1996, and by 2001 The Joint Commission had incorporated pain assessment standards that pushed hospitals to screen every patient. The intent was compassionate and correct: stop ignoring pain.

The unintended consequence, however, was significant. Pressure to drive pain scores toward zero, combined with aggressive pharmaceutical marketing of opioids as low-risk, contributed to overprescribing and fueled the opioid crisis of the 2000s–2010s. In response, the framing has matured: The Joint Commission retired the rigid "fifth vital sign" mandate, and modern practice emphasizes function over a single number, multimodal analgesia, and cautious opioid stewardship. The history is a lesson every nurse should carry: a good idea (never ignore pain) implemented crudely (a number to be zeroed) can cause real harm. Assess pain seriously — and treat it wisely.

Assessing Pain: Believe, Then Measure

Self-report is the gold standard. When a patient can communicate, their rating is the primary data point, even if it seems inconsistent with their appearance — patients with chronic pain may smile and talk while reporting an 8. A structured assessment prevents you from missing key features. The PQRST or OLDCARTS mnemonics organize the interview:

  • P – Provocation/Palliation: what makes it better or worse?
  • Q – Quality: sharp, dull, burning, cramping, throbbing?
  • R – Region/Radiation: where is it, does it travel?
  • S – Severity: 0–10 scale.
  • T – Timing: constant or intermittent, onset, duration?

Match the tool to the patient:

  • Numeric Rating Scale (0–10): for cognitively intact adults.
  • Wong-Baker FACES: for children (roughly age 3 and up) and adults who prefer pictures.
  • FLACC (Face, Legs, Activity, Cry, Consolability): a behavioral scale for infants and nonverbal children.
  • CPOT or BPS: behavioral tools for critically ill, sedated, or intubated adults.
  • PAINAD: for advanced dementia, where self-report is unreliable.

Never assume a nonverbal patient has no pain. Grimacing, guarding, restlessness, tachycardia, hypertension, and diaphoresis can all signal pain — though vital signs are unreliable on their own and should never replace a behavioral assessment.

Worked example: A postoperative patient rates pain 8/10, points to the incision, describes it as "sharp when I move," and is guarding the abdomen. This is acute nociceptive pain. Contrast with a patient describing "burning, electric, pins-and-needles" pain down the leg — that is neuropathic pain, which often responds poorly to opioids and better to adjuvants like gabapentin or duloxetine. Correctly classifying the pain changes the treatment.

The WHO Analgesic Ladder and Multimodal Analgesia

The World Health Organization introduced its analgesic ladder in 1986, originally for cancer pain, and it remains a durable teaching framework:

StepPain intensityTypical agentsAdd at every step
1Mild (1–3)Acetaminophen, NSAIDsAdjuvants + non-drug measures
2Moderate (4–6)Weak opioids (codeine, tramadol) ± Step 1Adjuvants + non-drug measures
3Severe (7–10)Strong opioids (morphine, hydromorphone, fentanyl) ± Step 1Adjuvants + non-drug measures

Adjuvants are drugs whose primary purpose is not analgesia but which relieve specific pain types: anticonvulsants (gabapentin, pregabalin) and antidepressants (duloxetine, amitriptyline) for neuropathic pain; corticosteroids for inflammatory or bone pain; muscle relaxants for spasm.

The modern refinement is multimodal analgesia — combining agents with different mechanisms so each can be used at a lower dose, improving relief while limiting any single drug's side effects. For example, scheduled acetaminophen plus an NSAID plus a low-dose opioid controls postoperative pain far better than a large opioid dose alone, and is more opioid-sparing. This is the backbone of Enhanced Recovery After Surgery (ERAS) protocols.

A key safety note on Step 1: acetaminophen has a ceiling of about 4 g per 24 hours in healthy adults (often reduced to 2–3 g with liver disease or alcohol use), and it hides in many combination products — a leading cause of accidental hepatotoxicity. NSAIDs risk GI bleeding, renal injury, and cardiovascular events, so use caution in older adults and those with kidney disease.

Opioids: Powerful and Perilous

Opioids relieve pain by binding mu receptors in the central nervous system. They are indispensable for severe acute pain and cancer pain, but their most dangerous effect is dose-dependent respiratory depression. The single most important nursing principle: sedation precedes respiratory depression. A rising sedation level is your early warning — assess it with a scale like POSS (Pasero Opioid-induced Sedation Scale) before and after dosing. If a patient is difficult to rouse, hold the next dose and notify the provider, even if the respiratory rate still looks acceptable.

Nursing considerations for opioids:

  • Monitor: sedation, respiratory rate and depth, and SpO2 (with capnography for higher-risk patients). A rate under 8–10/min or increasing sedation demands action.
  • Constipation is universal and does not resolve with tolerance — start a bowel regimen prophylactically.
  • Manage nausea, pruritus, and urinary retention as they arise.
  • Naloxone reverses opioid overdose; give per protocol for unresponsive respiratory depression, and be ready to redose because its half-life is shorter than most opioids.
  • PCA (patient-controlled analgesia): only the patient presses the button. "PCA by proxy" — a family member pushing it while the patient sleeps — has caused fatal overdoses. Teach this explicitly.
  • Assess for tolerance, physical dependence, and, distinctly, addiction; opioid-tolerant patients need higher doses, and their reports must still be believed.

Case vignette: A patient on IV hydromorphone PCA becomes progressively harder to wake, with a respiratory rate of 7 and pinpoint pupils. Correct nursing action: stop the PCA, stimulate the patient, apply oxygen, call for help, and administer naloxone per protocol while monitoring for reversal and re-sedation. This sequence — recognize sedation, act early — is testable on the NCLEX and lifesaving at the bedside.

Non-Pharmacologic Methods

Non-drug measures are not "extras"; they are core interventions that are independent nursing actions (no order required) and reduce the amount of medication needed. They work partly through the gate control theory of pain — competing sensory input can modulate pain signals in the spinal cord.

  • Physical: repositioning, heat and cold (cold for acute inflammation, heat for muscle spasm), massage, TENS, immobilization or splinting, and early mobilization where appropriate.
  • Cognitive-behavioral: distraction, guided imagery, music, relaxation breathing, and patient education (knowing what to expect reduces pain and anxiety).
  • Environmental: reducing noise and light, clustering care to allow rest, and simple presence — Nightingale's insight endures.

These are especially valuable for chronic pain, where the goal shifts from eliminating pain to restoring function and quality of life.

Real-World Applications

  • Postoperative care: multimodal, opioid-sparing regimens plus early ambulation reduce complications and length of stay.
  • Palliative and end-of-life care: around-the-clock dosing with breakthrough doses; here, adequate opioid dosing for comfort is ethically appropriate even as death approaches (the principle of double effect).
  • Emergency department: rapid assessment and treatment of severe pain (e.g., sickle cell crisis, fractures), where implicit bias and undertreatment are documented risks — believe the patient.
  • Chronic pain management: functional goals, careful opioid stewardship, and referral to interdisciplinary teams.

Common Mistakes

  1. Treating vital signs instead of the patient's report. Nurses sometimes doubt a patient whose blood pressure and heart rate are normal despite a high pain rating. This is wrong: chronic pain patients often have normal vitals, and physiologic adaptation is real. Self-report is the standard — believe it and treat accordingly.

  2. Monitoring respiratory rate but ignoring sedation level. By the time the respiratory rate drops, the patient may already be in danger. Because sedation precedes respiratory depression, assess arousability with every opioid dose and hold the next dose for excessive sedation.

  3. Waiting until pain is severe before acting ("PRN chasing"). Letting pain escalate to 9/10 before medicating makes it far harder to control and often requires larger doses. For predictable pain, medicate proactively (before dressing changes or physical therapy) and use scheduled dosing when appropriate.

Other frequent errors worth noting: stacking acetaminophen across combination products past 4 g/day, forgetting a prophylactic bowel regimen, and failing to reassess after an intervention.

Comparison and Connections

FeatureAcute painChronic pain
DurationLess than 3–6 monthsMore than 3–6 months
PurposeProtective warningServes no useful function
Vital signsOften elevatedOften normal
GoalRelieve, treat causeRestore function, quality of life
Opioid roleOften appropriate, short-termCautious, limited
FeatureNociceptive painNeuropathic pain
SourceTissue/organ injuryNerve damage
QualityAching, sharp, throbbingBurning, shooting, tingling
Best respondersOpioids, NSAIDsAnticonvulsants, antidepressants

Related concepts often confused: tolerance (needing more drug for the same effect), physical dependence (withdrawal on abrupt stop — expected and not addiction), and addiction (compulsive use despite harm). Also distinguish pseudoaddiction — drug-seeking behavior driven by genuinely undertreated pain that resolves once pain is controlled.

Practice Questions

Recall

Q: What is the gold standard for pain assessment in a communicative patient? A: The patient's own self-report. Rationale: pain is subjective; McCaffery's principle holds that pain is whatever the patient says it is, existing whenever they say it does. Behavioral and physiologic signs supplement but never replace self-report.

Understanding

Q: Why must a nurse assess sedation level, not just respiratory rate, in a patient receiving opioids? A: Because sedation precedes respiratory depression. Increasing sedation is the earliest warning sign; by the time the respiratory rate falls, the patient may already be compromised. Detecting rising sedation allows the nurse to hold the dose and intervene before harm occurs.

Application

Q: A postoperative patient reports incisional pain of 6/10 and is due for scheduled acetaminophen and an as-needed opioid. Physical therapy is in 30 minutes. What is the best nursing action? A: Administer analgesia proactively before physical therapy so the peak effect coincides with activity, and add non-pharmacologic measures (positioning, ice). Rationale: pre-emptive, multimodal analgesia controls predictable pain better than waiting until it becomes severe, and supports early mobilization.

Analysis

Q: A patient on a hydromorphone PCA is now difficult to arouse with a respiratory rate of 7 and pinpoint pupils. Rank the nurse's actions. A: Stop the PCA, stimulate the patient and ensure airway/oxygen, call for help, and administer naloxone per protocol; then monitor closely for re-sedation because naloxone's duration is shorter than the opioid's. Rationale: this is opioid-induced respiratory depression, a medical emergency where early recognition of sedation and prompt reversal are lifesaving.

FAQ

Is it true that patients get addicted easily when we treat their pain in the hospital? Genuine addiction arising from appropriate short-term treatment of acute pain is uncommon, though not zero. Fear of addiction historically caused widespread undertreatment. The balanced approach: treat pain adequately, use the lowest effective opioid dose for the shortest necessary time, favor multimodal and non-drug measures, and screen for risk factors.

If vital signs are normal, is the patient really in pain? Yes, possibly. Especially in chronic pain, the body adapts and vital signs normalize. Never use normal vitals to dismiss a pain report.

Why give acetaminophen and an NSAID and an opioid together — isn't one enough? Because they work by different mechanisms, combining them (multimodal analgesia) gives better relief at lower doses of each, particularly reducing opioid requirements and side effects.

Can I give more opioid than ordered if the patient is still in severe pain? No. Administer within the order. If pain remains uncontrolled, reassess, use adjuncts and non-drug measures, and contact the provider for an order adjustment. Acting outside your scope is unsafe and unlawful.

What do I do if a patient is on the PCA but a family member is pushing the button for them? Stop it immediately and educate the family: PCA is patient-controlled by design as a built-in safety feature. "PCA by proxy" bypasses the patient's own sedation as a limiter and has caused fatal overdoses.

Quick Revision

  • Pain is subjective; self-report is the gold standard — believe the patient.
  • Assess with a validated tool: 0–10, FACES, FLACC (nonverbal children), CPOT/BPS (ICU), PAINAD (dementia).
  • WHO ladder: Step 1 non-opioids → Step 2 weak opioids → Step 3 strong opioids, with adjuvants and non-drug measures at every step.
  • Multimodal analgesia is opioid-sparing and preferred.
  • Sedation precedes respiratory depression — assess arousability with every opioid dose; keep naloxone available.
  • Acetaminophen ceiling ~4 g/24 h (less with liver disease); watch hidden acetaminophen in combos.
  • Start a bowel regimen with opioids; constipation does not resolve with tolerance.
  • Reassess after every intervention; medicate predictable pain proactively.
  • Distinguish tolerance vs. dependence vs. addiction; recognize pseudoaddiction.
  • Always work within provider orders and your scope; escalate uncontrolled pain.

Prerequisites

Next Topics